Expands access to much-needed iron therapy for millions of US patients Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches Strengthens US supply of ...
On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated New Drug Application (ANDA) for Iron Sucrose Injection, USP 50mg/2.5mL, ...
Panelists discuss how chronic kidney disease leads to iron deficiency anemia through a complex interplay of impaired iron absorption, increased hepcidin production driven by inflammatory cytokines, ...
(RTTNews) - Viatris (VTRS) announced the FDA has approved Iron Sucrose Injection, USP, an intravenous iron replacement product used to treat iron deficiency anemia in adult and pediatric patients with ...
Please provide your email address to receive an email when new articles are posted on . IV iron is the most cost-effective option for women with iron deficiency anemia and heavy menstrual bleeding.
Verywell Health on MSN
Should you consider taking iron supplements for anemia?
Iron supplements help treat iron-deficiency anemia by increasing iron and hemoglobin levels. People who menstruate, are pregnant, or have certain medical conditions are at higher risk of iron ...
According to the FDA, Amphastar's iron sucrose injection meets the criteria for bioequivalence and therapeutic equivalence to Venofer ® for the treatment of iron deficiency anemia in patients with ...
The US Food and Drug Administration (FDA) has approved ferric carboxymaltose injection (Injectafer) for the treatment of iron-deficiency anemia (IDA) in adults who either cannot tolerate or have not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results